Inventor
COOKE JOHN P
US26 patents
⚠️ This page may combine multiple inventors who share the name “COOKE JOHN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
16 patentsUS5891459AApr 6, 1999
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR262 citations98
US5428070AJun 27, 1995
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
UNIV LELAND STANFORD JUNIOR226 citations98
US5945452AAug 31, 1999
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR105 citations97
US6646006B2Nov 11, 2003
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR66 citations96
US6642208B2Nov 4, 2003
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR33 citations96
US6117872ASep 12, 2000
Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR159 citations96
US5861168AJan 19, 1999
Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
UNIV LELAND STANFORD JUNIOR126 citations93
US7452916B2Nov 18, 2008
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR14 citations92
US6337321B1Jan 8, 2002
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
UNIV LELAND STANFORD JUNIOR25 citations92
US5852058ADec 22, 1998
Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
UNIV LELAND STANFORD JUNIOR65 citations91
US6605115B1Aug 12, 2003
Method and composition for inhibiting cardiovascular cell proliferation
UNIV LELAND STANFORD JUNIOR58 citations90
US9738873B2Aug 22, 2017
Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA
UNIV LELAND STANFORD JUNIOR5 citations82
US10760061B2Sep 1, 2020
Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA
UNIV LELAND STANFORD JUNIOR3 citations71
US10264974B2Apr 23, 2019
High resolution imaging using near-infrared-II fluorescence
UNIV LELAND STANFORD JUNIOR2 citations66
US11884937B2Jan 30, 2024
Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA
UNIV LELAND STANFORD JUNIOR0 citations61
US9011882B2Apr 21, 2015
Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof
UNIV LELAND STANFORD JUNIOR0 citations31
VERMILLION INC
3 patentsUS8377646B2Feb 19, 2013
Beta-2 microglobulin as a biomarker for peripheral artery disease
VERMILLION INC2 citations62
US8008020B2Aug 30, 2011
Biomarkers for peripheral artery disease
VERMILLION INC3 citations61
US8709735B2Apr 29, 2014
β-2 microglobulin as a biomarker for peripheral artery disease
VERMILLION INC0 citations45